Stocktoria

NewAmsterdam Pharma Co N.V. NAMS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-11-23

NewAmsterdam Pharma Co N.V. statistics & valuation

Market cap$3.9B
P / B5.7×
Net margin-905.7%
Return on equity-29.8%
Return on capital-33%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-22.00% -1255.80% -530.30% -905.70% 2022202320242025
Gross margin (%)
2022202320242025
Operating margin (%)
-3.50% -1298.60% -386.90% -1002.90% 2022202320242025
Return on equity (%)
-5.30% -61.40% -31.90% -29.80% 2022202320242025
Shares outstanding
81.6M 82.5M 108.1M 118.4M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-4.70% -51.00% -27.90% -26.50% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$1.19 -$2.15 -$2.56 -$1.72 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Operating margin-1002.9%-386.9%-1298.6%-3.5%
Net margin-905.7%-530.3%-1255.8%-22.0%
Return on assets-26.5%-27.9%-51.0%-4.7%
Return on equity-29.8%-31.9%-61.4%-5.3%
Current ratio7.888.086.9513.26

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.